Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. Nayak

175P: ALK Positive Lung Cancer: Clinical Profile and Outcomes in a Developing Country

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

P3.15-31 Better Clinical Outcomes and Resistance Mechanisms of Crizotinib in ALK-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-Generation ALK Inhibitor: A Monoinstitutional Experience

English

Clinical Feature and Survival Outcomes of Lung Cancer With ALK Mutation Positive and Treated With Crizotinib, Single Centre Experience

Acta Oncologica Turcica

English

ALK Is a Critical Regulator of the MYC-signaling Axis in ALK Positive Lung Cancer

English

P1.02-05 ALK Positive Lung Cancer: Patient Engagement and Partnership

Journal of Thoracic Oncology

Respiratory Medicine

English

Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK Inhibitor

Clinical Cancer Research

Cancer Research

English

Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer

OncoTargets and Therapy

English

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology

Cancer Research

English

P087 TNM Staging Inversely Correlates With Age in ALK-positive Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English